TCL Archive VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial May 30, 2014
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive In Brief: Appelbaum Clinical Dib. At Hutchinson; Vogelstein Win Pezcoller Award; Curiel To UAB July 23, 1993